CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208623253
- Phone
- 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- 4 Planned sale Chief Medical Officer sold 20,272 shares at $7.00 ($141,904)
- 4 Planned sale See Remarks sold 10,000 shares at $7.00 ($70,000)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- 4 Planned sale President and CEO sold 91,343 shares at $6.03 ($551,191)
- 4 Planned sale See Remarks sold 10,000 shares at $6.30 ($63,000)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale President and CEO sold 400 shares at $6.00 ($2,400)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Operating Officer sold 62,180 shares at $5.00 ($310,900)
- 4 Planned sale See Remarks sold 15,000 shares at $5.30 ($79,500)
- 8-K Event Regulation FD disclosure
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure
- 4 Grant or award Chief Commercial Officer acquired 25,000 shares (grant or award)
Page 6 of 35 · 689 filings